| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Aug―03 |
Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact |
Javier Olazarán, Cristóbal Carnero-Pardo, Juan Fortea, Pascual Sánchez-Juan, Guillermo García-Ribas, Félix Viñuela, et al. (+2) Pablo Martínez-Lage, Mercè Boada |
| 2 |
[GO] |
2023―Apr―15 |
Steeper memory decline after COVID-19 lockdown measures |
Els D. Bakker, Stéphanie L. van der Pas, Marissa D. Zwan, Freek Gillissen, Femke H. Bouwman, Philip Scheltens, et al. (+2) Wiesje M. van der Flier, Ingrid S. van Maurik |
| 3 |
[GO] |
2023―Jan―06 |
Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project |
Juraj Secnik, Maria Eriksdotter, Hong Xu, Martin Annetorp, Aleksander Rytarowski, Kristina Johnell, et al. (+2) Sara Hägg, Dorota Religa |
| 4 |
[GO] |
2022―Sep―06 |
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid? |
Muge Akinci, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, Cleofé Peña-Gómez, Eleni Palpatzis, Mahnaz Shekari, et al. (+32) Carme Deulofeu, Sherezade Fuentes-Julian, Gemma Salvadó, José Maria González-de-Echávarri, Marc Suárez-Calvet, Carolina Minguillón, Karine Fauria, José Luis Molinuevo, Juan Domingo Gispert, Oriol Grau-Rivera, Eider M. Arenaza-Urquijo, Annabella Beteta, Raffaele Cacciaglia, Alba Cañas, Irene Cumplido, Ruth Dominguez, Maria Emilio, Carles Falcon, Laura Hernandez, Gema Huesa, Jordi Huguet, Paula Marne, Tania Menchón, Grégory Operto, Albina Polo, Blanca Rodríguez-Fernández, Sandra Pradas, Iman Sadeghi, Anna Soteras, Laura Stankeviciute, Marc Vilanova, Natalia Vilor-Tejedor |
| 5 |
[GO] |
2021―Dec―20 |
Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study |
Lon S. Schneider, Yuqi Qiu, Ronald G. Thomas, Carol Evans, Diane M. Jacobs, Shelia Jin, et al. (+7) Jeffrey A. Kaye, Andrea Z. LaCroix, Karen Messer, David P. Salmon, Mary Sano, Kimberly Schafer, Howard H. Feldman |
| 6 |
[GO] |
2021―Jun―12 |
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again? |
Nian Xiong, Martin R. Schiller, Jingwen Li, Xiaowu Chen, Zhicheng Lin |
| 7 |
[GO] |
2021―Jun―09 |
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment |
Yadi Zhou, Jielin Xu, Yuan Hou, James B. Leverenz, Asha Kallianpur, Reena Mehra, et al. (+5) Yunlong Liu, Haiyuan Yu, Andrew A. Pieper, Lara Jehi, Feixiong Cheng |
| 8 |
[GO] |
2021―Apr―10 |
COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients |
Agathe Vrillon, Elsa Mhanna, Clément Aveneau, Manon Lebozec, Lina Grosset, Diane Nankam, et al. (+11) Fernanda Albuquerque, Raphaelle Razou Feroldi, Barbara Maakaroun, Iana Pissareva, Dalenda Cherni Gherissi, Julien Azuar, Véronique François, Claire Hourrègue, Julien Dumurgier, Lisette Volpe-Gillot, Claire Paquet |
| 9 |
[GO] |
2020―Dec―30 |
Cognitive impact of COVID-19: looking beyond the short term |
Scott Miners, Patrick G. Kehoe, Seth Love |
| 10 |
[GO] |
2020―Jun―04 |
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease |
Michael T. Heneka, Douglas Golenbock, Eicke Latz, Dave Morgan, Robert Brown |
|
